Joseph Ciaffoni's Net Worth
$25.7 Million
Who is Joseph Ciaffoni?
Joseph Ciaffoni has an estimated net worth of $25.7 Million. This is based on reported shares across multiple companies, which include COLLEGIUM PHARMACEUTICAL, INC, Endo International plc, and SCIELE PHARMA, INC..
SEC CIK
Joseph Ciaffoni's CIK is 0001443841
Past Insider Trading and Trends
2021 was Joseph Ciaffoni's most active year for acquiring shares with 7 total transactions. Joseph Ciaffoni's most active month to acquire stocks was the month of December. 2022 was Joseph Ciaffoni's most active year for disposing of shares, totalling 22 transactions. Joseph Ciaffoni's most active month to dispose stocks was the month of May. 2022 saw Joseph Ciaffoni paying a total of $1,252,125.00 for 268,784 shares, this is the most they've acquired in one year. In 2022 Joseph Ciaffoni cashed out on 363,778 shares for a total of $5,878,904.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.28
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +61.77% | 169.87K |
$33.70 | -$4,342,817.90 | 444.87K |
Feb 12
| |||
Form 4
|
—
|
0
|
$25.86 | -$39,398.17 | 275K |
Scheduled
|
Dec 21
| ||
Form 4
|
—
|
0
|
$25.76 | -$607,577.19 | 275K |
Scheduled
|
Dec 18 - Dec 20
| ||
Form 4
| -18.53% | -62.54K |
$21.84 | -$1,366,181.82 | 275K |
Jun 1 - Jun 2
| |||
Form 4
| -15.63% | -62.54K |
$21.88 | -$1,368,703.50 | 337.54K |
May 30 - May 31
| |||
Form 4
| +60.84% | 151.34K |
$21.33 | -$3,080,574.75 | 400.09K |
Scheduled
|
Feb 10 - Feb 13
| ||
Form 4
| -0.98% | -2.46K |
$23.67 | -$58,251.60 | 248.75K |
Scheduled
|
Dec 22 - Dec 27
| ||
Form 4
| -6.63% | -17.84K |
$23.08 | -$411,840.22 | 251.21K |
Scheduled
|
Dec 19 - Dec 21
| ||
Form 4
| -16.82% | -54.40K |
$19.31 | -$1,758,618.21 | 269.05K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
|
—
|
0
|
$18.95 | -$262.30 | 323.45K |
Scheduled
|
Nov 28
| ||
Form 4
|
—
|
0
|
$18.95 | -$396.50 | 323.45K |
Scheduled
|
Nov 22
| ||
Form 4
|
—
|
0
|
$18.96 | -$12,172.68 | 323.45K |
Scheduled
|
Nov 18
| ||
Form 4
| -0.43% | -1.39K |
$18.16 | -$25,315.04 | 323.45K |
Jul 1
| |||
Form 4
| -18.98% | -76.09K |
$18.47 | -$1,405,224.15 | 324.85K |
Scheduled
|
Mar 1
| ||
Form 4
| +51.93% | 137.04K |
$17.63 | -$934,337.11 | 400.94K |
Feb 10
| |||
Form 4
| -0.41% | -1.09K |
$18.68 | -$20,361.20 | 263.9K |
Jan 3
| |||
Form 4
| -0.52% | -1.39K |
$19.03 | -$26,375.58 | 264.99K |
Aug 10
| |||
Form 4
| -0.52% | -1.39K |
$23.99 | -$33,442.06 | 266.38K |
Jul 1
| |||
Form 4
| -3.78% | -10.53K |
$15.64 | -$483,385.36 | 267.77K |
Scheduled
|
Jun 1 - Jun 2
| ||
Form 4
| -5.49% | -16.15K |
$15.45 | -$1,068,801.22 | 278.31K |
Scheduled
|
Mar 1
| ||
Form 4
| -7.47% | -23.79K |
$25.95 | -$617,246.70 | 294.46K |
Feb 10
| |||
Form 4/A
| +72.72% | 133.99K |
—
|
—
| 318.25K |
Jan 19
| |||
Form 4
| +72.72% | 133.99K |
—
|
—
| 318.25K |
Jan 19
| |||
Form 4
| -0.59% | -1.09K |
$20.03 | -$21,832.70 | 184.26K |
Jan 4
| |||
Form 4
| -2.46% | -4.67K |
$18.49 | -$86,385.28 | 185.35K |
Nov 30
| |||
Form 4
| -0.72% | -1.39K |
$18.89 | -$26,181.54 | 190.02K |
Aug 10
| |||
Form 4
| -0.72% | -1.39K |
$17.37 | -$24,213.78 | 191.4K |
Jul 1
| |||
Form 4
| -7.83% | -16.39K |
$14.83 | -$1,208,179.83 | 192.8K |
Scheduled
|
Jun 1 - Jun 2
| ||
Form 4
| -3.46% | -7.50K |
$21.62 | -$162,128.38 | 209.19K |
Feb 10
| |||
Form 4
| +26.21% | 45K |
—
|
—
| 216.69K |
Feb 5
| |||
Form 4
| -0.63% | -1.09K |
$20.58 | -$22,452.78 | 171.69K |
Jan 2
| |||
Form 4
| -2.64% | -4.68K |
$21.73 | -$101,652.94 | 172.78K |
Nov 29
| |||
Form 4
|
—
|
0
|
$13.50 | -$683,945.49 | 177.46K |
Scheduled
|
Nov 7
| ||
Form 4
| -0.52% | -919.00 |
$11.24 | -$10,329.56 | 177.46K |
Aug 9
| |||
Form 4
| -1.03% | -1.85K |
$13.21 | -$24,412.08 | 178.37K |
Jul 1
| |||
Form 4
| -8.33% | -16.38K |
$11.55 | -$189,233.23 | 180.22K |
Scheduled
|
May 31 - Jun 3
| ||
Form 4
| -1.03% | -2.05K |
$14.39 | -$29,528.28 | 196.61K |
Feb 8
| |||
Form 4
| +82.83% | 90K |
—
|
—
| 198.66K |
Jan 25
| |||
Form 4
| -4.13% | -4.68K |
$19.19 | -$89,866.77 | 108.66K |
Nov 30
| |||
Form 4
| +28.50% | 25.14K |
—
|
—
| 113.34K |
Jul 1
| |||
Form 4
| -19.28% | -21.07K |
$15.41 | -$1,407,241.35 | 88.2K |
Scheduled
|
May 31 - Jun 1
| ||
Form 4
| +29.67% | 25K |
—
|
—
| 109.27K |
Jan 25
| |||
Form 4
|
∞
| 84.27K |
—
|
—
| 84.27K |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Endo International plc (ENDPQ) Snapshot price: $0.0007
President, U.S. Branded Pharma
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 52.36K |
—
|
—
| 52.36K |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCIELE PHARMA, INC. No price found
Executive V.P. & CCO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||